HPHAd is not paying dividends to its shareholders.
The last earnings report, released on Nov 30, 2016, missed the consensus estimates by -0.1682%.On average, the company has fell short of earnings expectations by -0.1352%, based on the last three reports.
Heidelberg Pharma AG has completed 9 stock splits, with the recent split occurring on Nov 07, 2017.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on LSE (EUR).